quinacrine has been researched along with harmalol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, AA; Arnold, LA; Bateman, R; Baxter, JD; Estébanez-Perpiñá, E; Fletterick, RJ; Guy, RK; Mar, E; Nguyen, P; Pallai, P; Rodrigues, ED; Shokat, KM; Webb, P | 1 |
| Adami, V; Astolfi, A; Barreca, ML; Biasini, E; Biggi, S; Bonetto, V; Dalle Vedove, A; Gatto, P; Lolli, G; Luotti, S; Massignan, T; Pancher, M; Stincardini, C | 1 |
2 other study(ies) available for quinacrine and harmalol
| Article | Year |
|---|---|
A surface on the androgen receptor that allosterically regulates coactivator binding.
Topics: Allosteric Site; Androgen Receptor Antagonists; Animals; Crystallography, X-Ray; In Vitro Techniques; Mice; Models, Molecular; Nuclear Receptor Coactivator 2; Protein Structure, Tertiary; Receptors, Androgen; Recombinant Proteins | 2007 |
Identification of compounds inhibiting prion replication and toxicity by removing PrP
Topics: Animals; Casein Kinase II; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Evaluation, Preclinical; Fluorescent Dyes; Gene Expression; Green Fluorescent Proteins; Harmaline; HEK293 Cells; Hematoxylin; Humans; Mice; Neuroblastoma; Prions; PrPC Proteins; Quinacrine; Tacrolimus | 2020 |